The liquid biopsy market is witnessing unprecedented volume growth, anticipated to reach USD 27.34 billion by 2035, alongside a significant CAGR of 10.52%. As healthcare systems increasingly prioritize minimally invasive diagnostic methods, the demand for liquid biopsies is surging. These tests provide a compelling alternative to traditional tissue biopsies, allowing for earlier detection and...